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The  question  of  whether  or  not  lymphoid  cells  can  cooperate  across  a 
histocompatibility difference barrier  has been studied in several laboratories. 
Using an adoptive transfer system, Katz et al.  (1) first showed that T cells from 
(low responder  ×  high responder) FI mice, primed to the terpolymer L-glutamic 
acid, L-lysine, L-tyrosine (GLT), could collaborate with 2,4-dinitrophenyl (DNP)- 
primed  B  cells  from  a  high  responder,  but  not  a  low  responder  strain,  in 
response to DNP-GLT. The response to GLT is under H-2-1inked Ir gene control. 
In contrast, studies with mouse bone marrow chimeras have shown that T cells 
can  interact  with H-2-histoincompatible  B  cells  in  response  to  antigens  not 
under Ir gene control (2-4). Another type of chimera, the allophenic mouse, has 
been used to study possible histoincompatible  cell interactions  to a  number of 
antigens,  including  DNP-L-glutamic acid,  L-lysine,  L-alanine;  L-glutamic acid, 
L-alanine,  L-tyrosine;  L-glutamic  acid,  L-lysine,  L-phenylalanine;  and  poly-L 
(Tyr,  Glu)-poly  D,L-Ala-poly-L-Lys[T,G)-A-L]  (5-9).  The  response  to  each  of 
these antigens is under H-2-1inked Ir gene control. 
It was initially  reported  (8,  9) that  in allophenic  mice containing  both high 
and low responder cells,  the antibody to (T,G)-A-L was of both the high and 
low responder  allotype.  This  was  interpreted  to  mean  that  high  responder T 
cells  had  cooperated  with  low  responder  B  cells  across  a  histocompatibility 
difference barrier  in the environment  of the  allophenic  mice.  However, Press 
and  McDevitt  (10)  have  recently reported  that  additional  and  more  accurate 
analyses of these  allophenic  mouse sera  failed  to detect any anti-(T,G)-A-L 
antibody of the low responder allotype. Moreover, in an experiment using bone 
marrow  chimeras,  there  was no low responder  allotype antibody produced in 
response to (T,G)-A- L(10). 
The present study was undertaken to test the immune response of allophenic 
mice to an  antigen,  DNP-bovine gamma  globulin  (DNPseBGG),  known  to be 
controlled  by genes both inside  and  outside the H-2  complex  (11,  12). 1 When 
high and low responder cells to DNP~BGG are present in allophenic mice, only 
antibody of the high  responder  allotype is produced.  The results suggest that 
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cell  cooperation  in  allophenic  mice  cannot  occur  across  a  histocompatibility 
difference barrier in response to an  antigen  whose genetic control is at least 
partially within the H-2 complex. 
Materials and Methods 
Mice.  The inbred strains A and C57BL/6 were purchased from The Jackson Laboratory, Bar 
Harbor, Maine. The F1 hybrids (A  ×  C57BL/6) were bred in our laboratory. The allophenic mice 
were produced as previously described (5). 
Immunization.  The immunization schedule was according to Newton and Warner (11).  Mice 
received 50  ~g of DNP~BGG  in  1 mg A1COH):~ (dry weight) administered intraperitoneally on 
days 1, 29, and 57. The animals were bled, sacrificed, and their spleens were excised on day 64. 
Spleen Cell Composition of Allophenic Mice.  After spleen excision,  a  single cell suspension 
was  prepared,  the  lymphocytes  were  isolated  on  a  Ficoll-Hypaque  density  gradient,  and  the 
proportion of C57BL/6 parental cells was determined by a trypan blue dye exclusion microcytotox- 
icity test (6).  The anti-C57BL/6 serum was produced by the injection of C57BL/6 spleens into A 
mice to eliminate any possible cross-reaction with A parental type spleen cells. 
Assays for DNP Antibody.  Two different radioimmunoassay procedures were used to measure 
serum antibody levels. The first was a  modification of the procedure of Green et al.  (13).  In this 
procedure,  [3H]DNP-lysine synthesized in our laboratory by the method of Stupp et al.  (14) was 
used as the antigen, and (NH0._,SO4 was used to precipitate the antibody-hapten complex (11). The 
second procedure  was  according to  Freed  et al.  (12).  In this procedure  ~2SI-DNP-bovine serum 
albumin (BSA), synthesized in our laboratory by the method of Greenwood and Hunter (15),  was 
used as the antigen,  and rabbit anti-mouse immunoglobulin (Miles Laboratories Inc., Elkhart, 
Ind.) was used to precipitate the antibody-antigen complex. Values <5% binding in this assay are 
insignificant. 
Allotype Analysis  of DNP Antibody.  Antibody  to  the  b  allotype  (C57BL/6)  was  prepared 
according to Herzenberg and Herzenberg (16).  Analysis using normal sera and myeloma proteins 
in double gel diffusion showed that the antiserum was monospecific for the b allotype. 
The immunoglobulin fraction was isolated from the anti-allotype serum by ammonium sulfate 
salt  fractionation,  and coupled  to cyanogen bromide-activated Sepharose  4B by the method of 
Cuatrecasas  (17).  A  1-ml column of immunoadsorbent was poured and equilibrated with 0.10 M 
sodium phosphate buffer, pH 7.0, containing 1.0 mg/ml BSA as a  carrier. The sera were assayed 
for anti-DNP antibody before application to the column. 10 tzl of immune sera were applied, and 
the column was incubated at room temperature for 1 h  to ensure complete binding. Then, 5 ml of 
buffer  was  passed  through  the  column  and  collected.  This  was  called  the  "passed  fraction". 
Elution of the antibody bound to the column was accomplished using 5 ml of 0.10 M  acetic acid, 
pH  3.1,  containing 1.0 mg/ml BSA.  This fraction, called the "eluted fraction", was neutralized 
with NaOH to pH 7.0-7.2.  Both fractions were then concentrated using a  Minicon B-15 (Amicon 
Corp., Lexington, Mass.) to a final volume of 0.5 ml (a 1:50 dilution of the original serum sample). 
The passed and eluted fractions were then assayed for anti-DNP antibody activity, as described 
above. 
Results 
Table I summarizes data collected in our laboratory which shows that A mice 
are high responders and C57BL/6 mice are low responders to DNP5sBGG.  Data 
is also shown for (A ×  C57BL/6)F1  hybrid mice. 
For the experiments described in this paper, 13 A ~  C57BL/6 allophenic mice 
were immunized with DNPssBGG.  Table II shows that the population of mice 
included a range of mixtures of parental spleen cell types. The allophenic mice 
studied  were not  assessed  for total  serum  allotype,  but rather  for spleen cell 
composition to determine their degree of chimerism. However, another study on 
C57BL/6  (-~  (CBA  ×  CBA/H-T6)  allophenic  mice  (18)  has  shown  that  the 
percentage of each parental cell type is the same when assayed either by spleen 
cell  composition  or  by  total  serum  allotype  composition.  The  response  to WARNER  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  I 
Response of  Inbred Strains of Mice to Immunization  with DNP5GBGG 
1851 
Mouse strain  No. of  mice  tested  ABC33 +- SEM*  Classification 
A  26  80 ± 5  High respender 
C57BL/6  31  10 ± 2  Low responder 
(A × C57BL/6)F~  10  97 ± 15  High responder 
* Data are the reciprocal  of the serum dilution for 33% binding of I0 " M  [3H]DNP-lysine.  ABC~, 
antigen binding capacity •t 33% antigen bound. 
TABLE  II 
Response of  A  <--> C57BL/6 Allophenic Mice to Immunization 
with DNPs~BGG 
Mouse  ~ C57BL16 SWBC*  ABC~3~: 
170  I  32 
171  I  88 
159  11  128 
191  12  100 
172  52  100 
173  59  65 
162  63  43 
160  72  26 
187  84  0 
168  95  33 
157  95  3 
158  97  9 
167  106  47 
* Data are the percentage of C57BL/6 spleen white blood cells (SWBC~ analyzed by cytotoxicity 
testing as described in the text. All assays were done in duplicate 
* Data are the reciprocal of the serum dilution  for 33% binding of 10 ~ M {3H]DNP-lysine.  All 
assays ware done in duplicate.  ABC~, antigen binding capacity at 33% antigen bound 
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FIG.  1.  Correlation  of the  antigen  binding  capacity at 33%  antigen  bound  (ABC.~3)  to the 
percentage  of C57BL/6  SWBC.  The line  is the  least squares  linear  regression through  all 
the data  points.  Number  of mice  =  13; r  =  -0.68; P  <  0.01. 
immunization was variable.  In general,  those mice with a higher proportion of 
low  responder  (C57BL/6)  sp.een  cells  produced  less  anti-DNP  antibody  in 
response to immunization  with DNP58BGG. This point is illustrated  in Fig.  1. 
Five of the mice listed in Table II were chosen for further experimentation. 
These  mice  were  assayed for the  presence  of the  low responder  b  (C57BL/6) 
allotype in the total  anti-DNP  antibody population,  as is shown in Table  III. 
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TABLE III 
Allotype Analysis of the Anti-DNP Antibody Produced by 
Inbred and Allophenic Mice iu Response to Immunization with 
DNP~sBGG* 
% Antigen bound 
Mouse  before anti-C57BLt6  % Antigen bound by  % Antigen bound by 
column  passed fraction  eluted fraction 
A  Ipooled)  27 ±  4  24 _+ 6  2 ±  0 
C57BL/6  (pooled)  20 -+ 3  6  ±  2  16 -+ 6 
170  32 -+ 3  29 -:_ 5  4  -+ 3 
171  37  -+  1  38 ±  1  5  -+ 3 
191  40 -+ 3  32  _* 8  3  -* 2 
172  38 -+ 5  37 +_ 10  2  ±  2 
162  33 -+ 0  28 -+  1  4  *-  1 
* All data are the percent  of antigen  0:~I-DNP-BSA) bound by a  1"50  serum dilution  Data are 
the average of duplicate determinations  -+ SD. 
some of the mice, none of them produced any significant antibody of the low 
responder (b) allotype. 
Discussion 
Allophenic mice provide an environment in which histoincompatible cells can 
coexist in a  single animal.  Since the cells coexist from a  very early stage of 
development, allophenic mice are potentially chimeric in all their tissues and 
organs.  They are therefore termed primary chimeras and  are  different from 
secondary chimeras, such as bone marrow chimeras, which are chimeric in only 
their lymphomyeloid system (19). The mechanisms for the establishment and 
maintenance of tolerance in allophenic mice or in bone marrow chimeric mice 
are unknown. However, it is clear that functional tolerance of the histoincom- 
patible cells does exist in both types of mice. 
In the present study, we have shown that the presence of two histoincompa- 
tible cell types in allophenic mice, one from a  high responder strain, and one 
from a  low responder strain to DNPs6BGG,  is not sufficient to allow the low 
responder cells to  produce  anti-DNP  antibody.  It  is  not  known if the  genes 
controlling the immune response to DNP56BGG are expressed at the level of the 
T cell, the B cell, the macrophage, or all three. Low responder (C57BL/6) B cells 
can make anti-DNP antibody when the DNP group is on a  carrier other than 
BGG (20). Thus, the inability to respond is probably at the T-cell or T cell-B cell 
interaction level. However, as is shown in the present study, in allophenic mice 
containing high responder T  cells capable of recognizing the carrier and low 
responder B cells capable of recognizing the hapten, antibody is not produced by 
the low responder B  cells.  A  likely explanation is that the high responder T 
cells  and low  responder  B  cells cannot cooperate  across  a  histocompatibility 
difference barrier  in response to an  antigen with genetic control residing in 
immune response gene(s) in the H-2 complex. This interpretation would be in 
full agreement with the recently reported data on the (T,G)-A-L system (10). 
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